Documento de consenso de las sociedades científicas españolas. Vacunas profilácticas frente al VPH

Cortés Bordoy, Javier; García de Paredes, Marisa; Muñoz Zato, Ernesto; Martinón Torres, Federico; Torné Blade, Aureli; García Rojas, Amós; Cisterna Cáncer, Ramón; Vidart Aragón, José Antonio; Abizanda González, Mercedes; Pipoll Lozano, Miguel Ángel; Vilaplana Vilaplana, Eduardo; Poveda Velasco, Andrés.
Prog. obstet. ginecol. (Ed. impr.) ; 52(1): 32-44, ene. 2009. tab
Artículo en Es | IBECS (España) | ID: ibc-71474

Documentos relacionados

  1. Could the human papillomavirus recombinant vaccine be a new valid approach in the management of ano-genital warts?
  2. A systematic review of the treatment of active anogenital warts with human papillomavirus vaccines.
  3. The impact of a universal human papilloma virus (HPV) vaccination program on lower genital tract dysplasia and genital warts.
  4. Changes in the Prevalence of Human Papillomavirus Genotypes in Genital Warts Since the Introduction of Prophylactic Vaccines.
  5. Nonavalent human papillomavirus vaccination as alternative treatment for genital warts.
  6. Gender-neutrality, herd effect and resilient immune response for sustainable impact of HPV vaccination.
  7. Genital Warts.
  8. Knowledge, Attitudes and HPV Vaccine Intention Among Women in India.
  9. Three cases of recalcitrant cutaneous warts treated with quadrivalent human papillomavirus (HPV) vaccine: the HPV type may not determine the outcome.
  10. HPV vaccination leads to decrease of anogenital warts and precancerous lesions of the cervix uteri in young women with low vaccination rates: a retrospective cohort analysis.